Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,148 | 138 | 97.4% |
| Education | $84.00 | 1 | 2.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $617.85 | 31 | $0 (2024) |
| Janssen Biotech, Inc. | $604.23 | 19 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $591.59 | 35 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $329.04 | 13 | $0 (2024) |
| Lilly USA, LLC | $190.06 | 9 | $0 (2024) |
| GENZYME CORPORATION | $182.79 | 4 | $0 (2024) |
| Ardelyx, Inc. | $165.17 | 8 | $0 (2024) |
| Medtronic, Inc. | $121.62 | 1 | $0 (2024) |
| QOL Medical, LLC | $105.23 | 5 | $0 (2024) |
| Digestive Care, Inc. | $62.35 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,637 | 116 | Janssen Biotech, Inc. ($550.79) |
| 2023 | $582.74 | 22 | ABBVIE INC. ($197.90) |
| 2021 | $13.14 | 1 | BOSTON SCIENTIFIC CORPORATION ($13.14) |
All Payment Transactions
139 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $13.05 | General |
| Category: Gastroenterology | ||||||
| 12/20/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $25.83 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/04/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $22.62 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/03/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $14.12 | General |
| 11/27/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.55 | General |
| Category: Gastroenterology | ||||||
| 11/27/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $10.49 | General |
| Category: Gastroenterology | ||||||
| 11/26/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $15.61 | General |
| Category: GI | ||||||
| 11/21/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $19.12 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/18/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $15.20 | General |
| Category: LIVER DISEASE | ||||||
| 11/13/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $24.23 | General |
| Category: THERAPY FOR CSID | ||||||
| 11/07/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $17.46 | General |
| Category: Immunology | ||||||
| 11/06/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $112.92 | General |
| Category: Immunology | ||||||
| 11/05/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $19.18 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/31/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $12.81 | General |
| Category: IMMUNOLOGY | ||||||
| 10/23/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $24.17 | General |
| Category: Immunology | ||||||
| 10/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $20.65 | General |
| Category: Gastroenterology | ||||||
| 10/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.33 | General |
| Category: Gastroenterology | ||||||
| 10/22/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $14.59 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/17/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $17.40 | General |
| Category: Immunology | ||||||
| 10/14/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $28.34 | General |
| Category: Immunology | ||||||
| 10/10/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), STELARA | Food and Beverage | In-kind items and services | $141.96 | General |
| Category: Immunology | ||||||
| 10/10/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $25.78 | General |
| Category: Immunology | ||||||
| 10/10/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $12.88 | General |
| Category: Gastroenterology | ||||||
| 10/09/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $26.59 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/09/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $8.48 | General |
| Category: Gastroenterology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 416 | 779 | $195,569 | $53,211 |
| 2022 | 17 | 610 | 1,183 | $232,992 | $85,036 |
| 2021 | 13 | 686 | 1,426 | $245,650 | $106,455 |
| 2020 | 16 | 714 | 1,374 | $225,150 | $98,700 |
All Medicare Procedures & Services
58 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99349 | Residence visit for established patient with moderate level of medical decision making, per day, if using time, at least 40 minutes | Office | 2023 | 125 | 391 | $110,653 | $28,082 | 25.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 69 | 69 | $20,562 | $7,210 | 35.1% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 23 | 29 | $13,543 | $3,613 | 26.7% |
| G0181 | Physician or allowed practitioner supervision of a patient receiving medicare-covered services provided by a participating home health agency (patient not present) requiring complex and multidisciplinary care modalities involving regular physician or allow | Office | 2023 | 22 | 41 | $9,635 | $2,759 | 28.6% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 38 | 65 | $5,980 | $2,579 | 43.1% |
| 99348 | Residence visit for established patient with low level of medical decision making, per day, if using time, at least 30 minutes | Office | 2023 | 30 | 51 | $9,333 | $2,264 | 24.3% |
| 99344 | Residence visit for new patient with moderate level of medical decision making, per day, if using time, at least 60 minutes | Office | 2023 | 29 | 29 | $11,455 | $2,076 | 18.1% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 20 | 21 | $3,948 | $1,341 | 34.0% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 15 | 34 | $2,856 | $1,023 | 35.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 15 | 15 | $2,040 | $892.20 | 43.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 11 | 11 | $2,804 | $814.44 | 29.0% |
| 99347 | Residence visit for established patient with straightforward medical decision making, per day, if using time, at least 15 minutes | Office | 2023 | 19 | 23 | $2,760 | $557.10 | 20.2% |
| 99336 | Established patient custodial care facility, group care, or assisted living visit, typically 40 minutes | Office | 2022 | 87 | 378 | $85,268 | $29,179 | 34.2% |
| 99349 | Established patient home visit, typically 40 minutes | Office | 2022 | 115 | 275 | $59,386 | $19,179 | 32.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 56 | 56 | $10,733 | $5,890 | 54.9% |
| 99497 | Advance care planning, first 30 minutes | Office | 2022 | 62 | 74 | $8,954 | $4,410 | 49.3% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 50 | 103 | $9,294 | $3,993 | 43.0% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 20 | 21 | $8,295 | $3,722 | 44.9% |
| 99495 | Transitional care management services for problem of moderate complexity | Office | 2022 | 22 | 26 | $9,517 | $3,391 | 35.6% |
| 99350 | Established patient home visit, typically 1 hour | Office | 2022 | 16 | 25 | $6,859 | $2,417 | 35.2% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2022 | 16 | 16 | $4,105 | $2,135 | 52.0% |
| 99337 | Established patient custodial care facility, group care, or assisted living visit, typically 1 hour | Office | 2022 | 17 | 18 | $7,018 | $2,073 | 29.5% |
| 99326 | New patient custodial care facility, group care, or assisted living visit, typically 45 minutes | Office | 2022 | 23 | 23 | $5,448 | $1,924 | 35.3% |
| 99491 | Chronic care management services for two or more chronic conditions, first 30 minutes provided personally by health care professional, per calendar month | Office | 2022 | 27 | 37 | $4,514 | $1,724 | 38.2% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 25 | 56 | $3,968 | $1,702 | 42.9% |
About Thomas Feeny, PA-C
Thomas Feeny, PA-C is a Physician Assistant healthcare provider based in Dayton, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/15/2006. The National Provider Identifier (NPI) number assigned to this provider is 1467478024.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Thomas Feeny, PA-C has received a total of $3,232 in payments from pharmaceutical and medical device companies, with $2,637 received in 2024. These payments were reported across 139 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($3,148).
As a Medicare-enrolled provider, Feeny has provided services to 2,426 Medicare beneficiaries, totaling 4,762 services with total Medicare billing of $343,401. Data is available for 4 years (2020–2023), covering 58 distinct procedure/service records.
Practice Information
- Specialty Physician Assistant
- Location Dayton, OH
- Active Since 07/15/2006
- Last Updated 08/09/2023
- Taxonomy Code 363A00000X
- Entity Type Individual
- NPI Number 1467478024
Products in Payments
- XIFAXAN (Drug) $443.98
- STELARA (Biological) $391.37
- RINVOQ (Biological) $321.89
- ENTYVIO (Biological) $301.42
- DUPIXENT (Biological) $207.22
- OMVOH (Drug) $169.70
- IBSRELA (Drug) $165.17
- TREMFYA (Drug) $159.42
- TRULANCE (Drug) $147.61
- VALLEYLAB FT10 (Device) $121.62
- MAVYRET (Drug) $77.33
- LINZESS (Drug) $75.03
- SUCRAID (Drug) $68.78
- CREON (Drug) $64.28
- Pertzye (Drug) $62.35
- REMICADE (Biological) $53.44
- SKYRIZI (Biological) $47.36
- TERLIVAZ (Drug) $42.93
- Sucraid (Drug) $36.45
- RESMETIROM (Drug) $36.31
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physician Assistant Doctors in Dayton
Emily Ankrom, Pa-C, PA-C
Physician Assistant — Payments: $103,850
Srikanth Vangapandu, Mph, Mspas, Pa-C, MPH, MSPAS, PA-C
Physician Assistant — Payments: $11,651
Mackenzie Tiderington, P.a-C, P.A-C
Physician Assistant — Payments: $11,297
Christine Beaujean, Pa, PA
Physician Assistant — Payments: $7,150
Alyssa Beach, Pa-C, PA-C
Physician Assistant — Payments: $5,771
Cassandra Williamson, Pa, PA
Physician Assistant — Payments: $4,849